Macro Group Pharmaceuticals (Macro Capital)E Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Macro Group Pharmaceuticals (Macro Capital)E's earnings have been declining at an average annual rate of -74.8%, while the Personal Products industry saw earnings growing at 8.6% annually. Revenues have been declining at an average rate of 7.7% per year.
Belangrijke informatie
-74.8%
Groei van de winst
-74.9%
Groei van de winst per aandeel
| Personal Products Groei van de industrie | 8.7% |
| Inkomstengroei | -7.7% |
| Rendement op eigen vermogen | -1,428.8% |
| Nettomarge | -113.6% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Macro Group Pharmaceuticals (Macro Capital)E geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 344 | -391 | 442 | 0 |
| 31 Mar 24 | 430 | -360 | 464 | 0 |
| 31 Dec 23 | 526 | -273 | 451 | 0 |
| 30 Sep 23 | 799 | 142 | 355 | 0 |
| 30 Jun 23 | 762 | 132 | 350 | 0 |
| 31 Mar 23 | 750 | 153 | 341 | 0 |
| 31 Dec 22 | 730 | 174 | 317 | 0 |
| 30 Sep 22 | 697 | 171 | 302 | 0 |
| 30 Jun 22 | 666 | 179 | 280 | 0 |
| 31 Mar 22 | 611 | 167 | 262 | 0 |
| 31 Dec 21 | 594 | 148 | 257 | 0 |
| 30 Sep 21 | 544 | 143 | 229 | 0 |
| 31 Dec 20 | 431 | 135 | 159 | 0 |
Kwaliteitswinsten: MCRO is currently unprofitable.
Groeiende winstmarge: MCRO is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: MCRO is unprofitable, and losses have increased over the past 5 years at a rate of 74.8% per year.
Versnelling van de groei: Unable to compare MCRO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: MCRO is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (10.9%).
Rendement op eigen vermogen
Hoge ROE: MCRO has a negative Return on Equity (-1428.78%), as it is currently unprofitable.